JPRN-UMIN000001439
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophagus - Ce CRT P-II
Conditionscervical esophageal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- cervical esophageal cancer
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.have lymph node metastases at neck level II area 2\.have active concomitant malignancy 3\.A Hbs antigen is positive 4\.pregnant or may be pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70
Completed
Phase 1
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
Unknown
Phase 1
Phase I/II Study of Satraplatin Plus RadiotherapyJPRN-jRCT2080221482Yakult Honsha Co.,Ltd.33